Best Blood Collection Tube Brands in the U.S.: BD Vacutainer, Greiner Bio-One VACUETTE, and SARSTEDT S-Monovette Compared

Summary

• BD Vacutainer, Greiner Bio-One VACUETTE, and SARSTEDT S-Monovette are among the most established blood collection tube systems available to U.S. laboratories, but reliability depends on the exact tube, additive, lot, instrument, and intended test.
• Purchasers should evaluate FDA status, CLSI compliance, specimen-quality performance, fill volume, expiration dating, packaging, supply continuity, and compatibility with laboratory analyzers rather than selecting a brand based only on name recognition.
• A documented receiving, validation, storage, lot-change, and recall-monitoring process is essential because many laboratory errors occur before analysis, during patient identification, collection, handling, transport, and processing.

Blood collection tubes are among the most frequently purchased items in a medical laboratory, hospital, physician office, urgent-care center, blood-draw service, and Mobile Phlebotomy operation. Although tubes may appear to be simple consumable products, their performance can directly influence Specimen Integrity, Test Results, redraw rates, Patient Satisfaction, regulatory compliance, and laboratory operating costs.

In the United States, the most recognized blood collection tube brands include BD Vacutainer, Greiner Bio-One VACUETTE, and SARSTEDT S-Monovette. Other suppliers, including Cardinal Health, McKesson private-label programs, Terumo, and regional or specialty manufacturers, may also offer suitable products. However, a brand name alone does not establish that every tube in that manufacturer’s catalog is appropriate for every test.

The correct purchasing decision requires evaluation at the product and application level. A serum tube, lithium-Heparin plasma tube, EDTA tube, citrate coagulation tube, trace-element tube, blood-culture bottle, or molecular diagnostic collection tube can have different additive concentrations, materials, stopper designs, draw-volume requirements, centrifugation conditions, and stability limits. A tube that performs well for one assay may be unsuitable for another.

What Makes a Blood Collection Tube Reliable?

Reliability means more than whether a tube fills with blood. A dependable tube should consistently maintain the characteristics required by the laboratory test from collection through processing and analysis. This includes the vacuum, internal volume, additive-to-blood ratio, clotting behavior, gel performance, stopper integrity, labeling, packaging, and compatibility with the laboratory’s equipment.

Preanalytical errors are especially important. Peer-reviewed laboratory-medicine reviews commonly report that approximately 60% to 70% of laboratory errors occur during the preanalytical phase, although the precise percentage varies by study design and setting. These errors can include wrong-patient identification, incorrect tube selection, inadequate mixing, hemolysis, clotting, insufficient volume, delayed transport, and improper storage. The collection tube cannot prevent every error, but its design and consistency can reduce some failure points.

For U.S. purchasers, a reliable blood collection tube generally has the following characteristics:

1. Consistent vacuum and dependable draw volume throughout the stated shelf life.
2. Correct additive concentration and uniform distribution inside the tube.
3. Low rates of hemolysis, clotting, leakage, cracked tubes, and stopper displacement.
4. Compatibility with the laboratory’s analyzers, centrifuges, automation lines, racks, and pneumatic-tube system.
5. Clear labeling that identifies tube type, additive, lot number, expiration date, and fill requirement.
6. Documented regulatory status and appropriate quality-system controls.
7. Stable availability through authorized U.S. distribution channels.

Leading Blood Collection Tube Brands in the United States

BD Vacutainer

BD Vacutainer is one of the most established blood collection systems in the United States. The brand is widely used in hospitals, reference laboratories, outpatient centers, physician offices, and public-health settings. Its broad product range includes serum tubes, serum-separator tubes, lithium-Heparin plasma tubes, EDTA tubes, sodium-citrate tubes, fluoride-containing tubes, trace-element tubes, specialty tubes, and blood-culture products.

One of BD’s major advantages is standardization. Many U.S. phlebotomists and laboratory professionals are already trained on the color coding, stopper styles, tube geometry, and order-of-draw conventions associated with BD products. Large health systems may also have established analyzer applications, automated specimen-processing settings, and supply contracts built around BD Vacutainer products.

The brand’s extensive U.S. distribution network can be important for high-volume purchasers. A hospital may need tens of thousands of tubes per month, while a small clinic may require only a few cases. A commonly used brand can simplify staff training, inventory management, and replacement purchasing.

BD products are not automatically interchangeable across all tube types or testing systems. A laboratory should verify the specific catalog number and intended use. For example, changing from one serum-separator tube to another may affect clot formation, gel barrier characteristics, specimen volume, or compatibility with a particular chemistry or immunoassay platform. The laboratory should review manufacturer instructions and perform local verification before changing products.

Greiner Bio-One VACUETTE

Greiner Bio-One’s VACUETTE system is another major brand used in the United States and internationally. VACUETTE tubes are available in common formats for serum, plasma, hematology, coagulation, glucose, trace-element, and specialty testing. Greiner Bio-One has a substantial reputation for tube manufacturing, specimen-collection systems, and preanalytical laboratory products.

A significant purchasing advantage is the breadth of the VACUETTE product family. Laboratories that use Greiner Bio-One tubes may be able to standardize several collection applications under one brand while maintaining consistent labeling and handling practices. The product line also includes safety blood-collection devices and accessories, allowing some organizations to coordinate tubes and collection equipment through a single supplier.

VACUETTE tubes are often considered when a laboratory wants an alternative to BD or needs a second qualified source. In some circumstances, a laboratory may use Greiner Bio-One as its primary supplier and maintain another manufacturer as a contingency source. This strategy can improve resilience during allocations, transportation interruptions, manufacturing constraints, or regional shortages.

As with every manufacturer, laboratories should not assume that a VACUETTE tube is interchangeable solely because it has the same stopper color as a competing tube. Color conventions are useful but are not sufficient for product identification. The additive, tube volume, material, gel formulation, and intended testing application must be confirmed.

SARSTEDT S-Monovette

SARSTEDT is well known for its S-Monovette blood collection system. The system differs from conventional evacuated tubes because S-Monovette products can use an aspiration principle, a vacuum principle, or both, depending on the product and collection method. This design can be attractive in settings where controlled blood withdrawal, reduced collection discomfort, or specialized collection techniques are important.

SARSTEDT offers tubes and collection systems for serum, plasma, hematology, coagulation, trace-element, and other applications. Its products are used in hospitals and laboratories worldwide, including U.S. facilities that value the manufacturer’s specialized collection technology and integrated approach.

The main purchasing consideration is Workflow compatibility. A laboratory that has been built around standard evacuated tubes may need different staff training, holders, adapters, or collection procedures when introducing S-Monovette products. The organization should evaluate needle systems, patient populations, tube sizes, order of draw, specimen transport, centrifugation, and analyzer loading before implementation.

SARSTEDT can be a particularly relevant option for pediatric, geriatric, oncology, difficult-access, or low-volume collection environments, but suitability depends on the specific product and local procedure. A purchasing team should compare actual redraw and rejection rates rather than relying on general claims about comfort or performance.

Other U.S. Sources and Private-Label Products

Hospitals and clinics may also encounter blood collection tubes sold under distributor or private-label brands. Cardinal Health, McKesson, Medline, and other medical-supply distributors may offer collection products from multiple manufacturers or private-label programs. These products can be cost-effective and may meet the needs of routine testing when their specifications and performance have been verified.

Private-label purchasing requires additional diligence. The organization should identify the actual manufacturer, not only the distributor’s brand name. It should obtain product specifications, regulatory documentation, certificates of analysis when appropriate, instructions for use, lot-traceability procedures, and information about manufacturing-site changes.

Lower unit cost does not necessarily mean lower total cost. A modest savings per tube can be eliminated by increased hemolysis, insufficient draws, Specimen Rejection, redraws, delayed results, staff time, or instrument downtime. For that reason, buyers should compare total cost per acceptable reportable specimen rather than price per box.

Comparing Brands by Tube Type

The best brand can vary by application. A laboratory may prefer one manufacturer for routine chemistry, another for coagulation, and a specialty supplier for trace-element testing. The following categories deserve separate evaluation.

Serum and Serum-Separator Tubes

Serum tubes are used for chemistry, immunology, serology, and many other assays. Serum-separator tubes contain a Clot Activator and gel designed to form a barrier between serum and cells after centrifugation. Important performance characteristics include Clotting Time, fibrin occurrence, gel movement, barrier stability, and suitability for the laboratory’s centrifuge settings.

BD Vacutainer and Greiner Bio-One VACUETTE are commonly evaluated for routine serum and serum-separator applications. SARSTEDT also provides serum collection products. The laboratory should test representative specimens from different patient groups, including patients with high hematocrits, low fibrinogen, Anticoagulant therapy, or difficult collections.

EDTA Tubes for Hematology

EDTA tubes are typically used for complete blood counts, platelet counts, blood films, and other hematology tests. The blood-to-EDTA ratio is important, particularly when the specimen may be used for tests sensitive to cell morphology or volume. Underfilling, overfilling, inadequate mixing, and delays can produce clots or inaccurate findings.

Purchasers should assess the tube’s ability to maintain cellular morphology over the laboratory’s stated testing interval. A tube may be acceptable for a routine complete blood count performed quickly but unsuitable for a specialized test sent to a reference laboratory. The laboratory must follow the assay manufacturer’s specimen requirements and its own validated stability limits.

Sodium-Citrate Tubes for Coagulation

Sodium-citrate tubes are highly sensitive to fill volume because coagulation testing depends on the proper ratio of blood to anticoagulant. The conventional target for many coagulation applications is a 9:1 blood-to-citrate ratio, although specific tests and patient conditions may require special handling.

Reliable citrate tubes must maintain the correct volume and provide clear fill markings. They should be evaluated for expiration performance, stopper design, and compatibility with the laboratory’s coagulation analyzers. Underfilled tubes can produce unacceptable results and are frequently rejected under laboratory quality procedures.

Special attention is required for patients with high hematocrits. When hematocrit exceeds approximately 55%, the laboratory may need to adjust the citrate volume according to its procedure and applicable guidance. This is a clinical and laboratory-process issue, not simply a brand issue.

Lithium-Heparin and Other Plasma Tubes

Lithium-Heparin tubes are commonly used for plasma chemistry and selected urgent-care applications. Buyers should evaluate gel performance, Anticoagulant concentration, plasma yield, carryover risk, and compatibility with the laboratory’s chemistry and immunoassay platforms.

Some assays are affected by Heparin, Separator Gel, or the presence of other additives. The laboratory should consult the assay manufacturer before adopting a new tube for therapeutic-drug monitoring, trace analysis, molecular testing, or specialized immunoassays.

Trace-Element and Specialty Tubes

Trace-element testing requires strict control of contamination from tube materials, additives, collection needles, work surfaces, and handling procedures. A tube advertised for trace elements should still be reviewed against the requirements of the specific test method and reference laboratory.

Specialty tubes may include tubes for lead, zinc, copper, aluminum, mercury, Drug Testing, molecular diagnostics, or blood bank applications. These products should be purchased only after confirming the required additive, material, specimen volume, and laboratory acceptance criteria.

Regulatory and Quality Considerations for U.S. Buyers

In the United States, blood collection tubes are medical devices subject to applicable Food and Drug Administration requirements. Depending on the product, the manufacturer may have a 510(k) clearance, another applicable regulatory pathway, or a product-specific status. Purchasers should confirm the regulatory status of the exact product rather than relying on a general statement that a manufacturer is FDA registered.

FDA establishment registration does not mean that every product is individually “approved,” and FDA clearance does not guarantee that a tube is suitable for every laboratory assay. The intended use, labeling, and performance claims must align with the purchaser’s application.

Manufacturers should also operate under appropriate quality-management controls. ISO 13485 certification can provide useful information about a manufacturer’s quality system, but certification alone is not a substitute for local product verification. Buyers should review complaint handling, lot traceability, change notification, recall communication, and supplier responsiveness.

Laboratories should align their collection procedures with recognized guidance, including applicable Clinical and Laboratory Standards Institute recommendations. CLSI documents address areas such as venous blood collection, order of draw, coagulation specimens, and specimen handling. The exact document and edition used should be identified in the laboratory’s quality system because guidance is periodically revised.

OSHA’s Bloodborne Pathogens Standard, found at 29 CFR 1910.1030, also affects collection operations. Although the standard does not select a blood tube brand, it requires employers to address exposure-control practices, engineering controls, work practices, training, and safer medical devices where applicable. Safety needles and other collection equipment should therefore be evaluated together with tubes.

How to Validate a New Tube Brand

Changing tube brands should be treated as a controlled laboratory change, not as a routine substitution. The extent of verification depends on the tube type, testing menu, patient population, and laboratory policy.

1. Identify every assay and department that uses the current tube.
2. Compare the current and proposed tube’s additive, volume, dimensions, material, stopper, gel, and intended use.
3. Confirm analyzer, centrifuge, automation, rack, transport, and pneumatic-tube compatibility.
4. Collect representative patient specimens across normal and abnormal concentration ranges.
5. Compare results, specimen appearance, hemolysis, clotting, fibrin, gel movement, and rejection rates.
6. Assess the tube under expected transport and storage conditions.
7. Document acceptance criteria, quality-control findings, staff training, and approval by the laboratory director or designated authority.
8. Monitor performance after implementation and compare redraw rates with the previous product.

Validation should include difficult or high-risk specimen types when relevant. For example, a pediatric setting may need to test low-volume tubes, while an emergency department may need to evaluate rapid transport, pneumatic-tube exposure, and short turnaround times. A coagulation laboratory should specifically investigate fill-volume errors and high-hematocrit specimens.

Purchasing and Supply-Chain Factors

Reliability includes the ability to obtain the product consistently. During the Covid-19 pandemic, many U.S. healthcare organizations experienced shortages or allocations involving collection tubes, swabs, transport media, and other laboratory supplies. That experience demonstrated the importance of dual sourcing, safety stock, supplier communication, and realistic demand forecasting.

Before signing a contract, purchasers should ask whether the distributor can provide manufacturer lot information, expiration dating, advance notice of product changes, and rapid notification of recalls or field corrections. They should also determine whether the quoted price applies to a fixed case quantity, whether partial cases are available, and whether shipping conditions affect the product.

Inventory levels should be based on usage, lead time, expiration dating, emergency demand, and supplier reliability. Excessive inventory can create waste when products expire, while insufficient inventory can force an unvalidated substitution. A practical policy may define minimum and maximum stock levels and identify an approved alternative product that can be activated through the laboratory’s change-control process.

Purchasers should inspect deliveries for crushed cartons, damaged tubes, missing labels, incorrect catalog numbers, short dating, and temperature or storage concerns. The receiving process should record lot numbers and expiration dates when the laboratory requires full traceability.

Storage, Handling, and Staff Training

Even a high-quality tube can fail when stored or handled incorrectly. Tubes should be stored according to the manufacturer’s instructions, protected from excessive heat, freezing, moisture, direct sunlight, and mechanical damage. Vacuum performance may be affected by age, temperature, or compromised packaging.

Staff should be trained on tube selection, patient identification, order of draw, fill volume, mixing, Clotting Time, transport, and rejection criteria. The order of draw is intended to reduce additive carryover between tubes. However, the laboratory’s procedure should specify the sequence for the exact devices and tube types in use.

Mixing requirements vary by additive. Tubes should be gently inverted the number of times specified by the manufacturer or laboratory procedure. Vigorous shaking can contribute to hemolysis, while inadequate mixing can lead to clotting or inaccurate results. Tubes should not be vigorously rolled, vortexed, or manually agitated unless the validated procedure specifically allows it.

How to Compare Cost and Performance

Price comparisons should include more than the invoice. A useful purchasing analysis can calculate the total cost of an acceptable specimen. This includes the tube, needle or collection set, labor, transport, storage, specimen-processing time, redraws, rejected tests, delayed treatment, and disposal.

For example, if a lower-priced tube increases Specimen Rejection by even a small percentage in a high-volume department, the resulting redraw labor and patient inconvenience may exceed the purchase savings. Conversely, a higher-priced tube may be economically justified if it reduces hemolysis, supports automation, or improves first-attempt collection success.

Laboratories should track key indicators before and after a product change. Useful measures include hemolysis index, clotted EDTA specimens, underfilled citrate tubes, mislabeled specimens, insufficient-volume specimens, recollection frequency, tube leakage, and turnaround-time delays. Results should be stratified by location and collector because performance may reflect Workflow or training rather than the tube alone.

Which Brand Should a U.S. Laboratory Choose?

For many U.S. laboratories, BD Vacutainer is a practical choice when broad product availability, staff familiarity, analyzer compatibility, and established distribution are priorities. Greiner Bio-One VACUETTE is a strong alternative or primary system for organizations seeking a widely recognized international manufacturer with a broad range of collection products. SARSTEDT S-Monovette may be especially attractive when its aspiration-and-vacuum collection approach, specialty products, or patient-comfort considerations fit the clinical Workflow.

There is no universal ranking that proves one brand is best for every hospital, clinic, or assay. A large academic medical center may value automation compatibility and global sourcing. A rural clinic may prioritize distributor availability and long shelf life. A pediatric center may focus on low-volume collection and patient comfort. A reference laboratory may emphasize transport stability and tube standardization across thousands of client sites.

The most reliable purchasing decision is therefore the brand and catalog number that meet the laboratory’s validated requirements, are available through a dependable Supply Chain, and maintain acceptable specimen-quality metrics over time.

Questions to Ask Before Placing an Order

1. Is the exact tube intended and labeled for the laboratory’s required test applications?
2. What are the additive, draw volume, fill tolerance, expiration period, and storage requirements?
3. Has the tube been evaluated with the laboratory’s analyzers, centrifuges, automation, and transport systems?
4. What quality certifications and regulatory documentation can the manufacturer provide?
5. How are lot changes, manufacturing changes, complaints, recalls, and field corrections communicated?
6. What is the supplier’s average lead time, fill rate, back-order history, and contingency plan?
7. Can the supplier provide sufficient remaining shelf life at delivery?
8. What are the return procedures for damaged, short-dated, or incorrect products?
9. What performance data will the laboratory monitor after implementation?
10. Is there an approved alternate product if the primary tube becomes unavailable?

Conclusion

BD Vacutainer, Greiner Bio-One VACUETTE, and SARSTEDT S-Monovette are among the most dependable and established blood collection tube systems available to U.S. purchasers. Each has a broad presence, recognized product families, and applications across hospital, outpatient, reference, and specialty laboratories. Other manufacturer and private-label products may also be appropriate when properly evaluated.

The safest approach is to choose based on documented performance rather than marketing reputation alone. Verify the exact product, confirm regulatory and technical requirements, conduct a local comparison, train staff, monitor rejection and redraw data, and maintain a supply-continuity plan. When these steps are followed, a laboratory can select a blood collection tube system that supports accurate testing, efficient operations, patient safety, and long-term purchasing reliability.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos